TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
9.68
+0.08 (0.83%)
Mar 9, 2026, 3:38 PM EDT - Market open
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $8.88 million as of March 9, 2026. Its market cap has increased by 29.30% in one year.
Market Cap
8.88M
Enterprise Value
5.94M
1-Year Change
29.30%
Ranking
Category
Stock Price
$9.68
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $8.88M, a decrease of -81.46%. That is a compound annual growth rate of -30.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 8.80M | 40.56% |
| Dec 31, 2025 | 6.26M | 166.92% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cardio Diagnostics Holdings | 10.17M |
| BioVie | 10.10M |
| CollPlant Biotechnologies | 9.53M |
| NuCana | 9.16M |
| SeaStar Medical Holding | 9.08M |
| Iterum Therapeutics | 8.49M |
| Bolt Biotherapeutics | 8.41M |
| Alaunos Therapeutics | 8.15M |